PLoS Biology (Nov 2022)
Drug-resistant bacterial infections: We need urgent action and investment that focus on the weakest link.
Abstract
Despite high mortality and morbidity, drug-resistant bacterial infections remain the forgotten pandemic. We argue for strengthening of diagnostics, WASH (water, sanitation, and hygiene) and infection prevention and control to reduce drug-resistant infections, as an integral part of sustainable high-quality health services, particularly in low- and middle-income countries.